Japan Lifeline Co., Ltd. (FRA:L8B)
Germany · Delayed Price · Currency is EUR | Market Cap | 592.93M -1.2% |
| Revenue (ttm) | 325.66M +5.7% |
| Net Income | 50.39M +0.8% |
| EPS | 0.72 +0.7% |
| Shares Out | n/a |
| PE Ratio | 11.77 |
| Forward PE | n/a |
| Dividend | 0.43 (5.09%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | n/a |
| Open | 8.30 |
| Previous Close | 8.25 |
| Day's Range | 8.30 - 8.30 |
| 52-Week Range | 6.65 - 8.75 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Japan Lifeline
Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablat... [Read more]
Financial Performance
In fiscal year 2026, Japan Lifeline's revenue was 59.19 billion, an increase of 4.55% compared to the previous year's 56.61 billion. Earnings were 9.35 billion, an increase of 0.35%.
Financial numbers in JPY Financial StatementsNews
Q1 2027 Japan Lifeline Co Ltd Earnings Presentation (Japanese) Transcript
Q1 2027 Japan Lifeline Co Ltd Earnings Presentation (Japanese) Transcript
Japan Lifeline Earnings Call Transcript: Q1 2027
Record Q1 net sales rose 8.8% year-over-year, but operating profit fell 9.4% due to higher R&D and personnel costs. Proprietary product launches and strong segment growth offset margin pressures, while guidance and dividend forecasts were raised to mark the 25th manufacturing anniversary.
Japan Lifeline Quarterly report: Q1 2027
Japan Lifeline has published its Q1 2027 quarterly earnings report on July 30, 2026.
Japan Lifeline Slides: Q1 2027
Japan Lifeline has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 30, 2026.
Japan Lifeline Earnings Call Transcript: Q4 2026
Record sales and profits were achieved, driven by strong core and new product growth, despite margin pressure from inflation and one-time costs. FY 2027 guidance anticipates continued top-line growth but lower profits due to higher investments and relocation expenses.
Japan Lifeline Slides: Q4 2026
Japan Lifeline has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 7, 2026.
Japan Lifeline Quarterly report: Q4 2026
Japan Lifeline has published its Q4 2026 quarterly earnings report on May 7, 2026.
Japan Lifeline Quarterly report: Q3 2026
Japan Lifeline has published its Q3 2026 quarterly earnings report on January 30, 2026.
Japan Lifeline Slides: Q3 2026
Japan Lifeline has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 30, 2026.
Q2 2026 Japan Lifeline Co Ltd Earnings Presentation (Japanese) Transcript
Q2 2026 Japan Lifeline Co Ltd Earnings Presentation (Japanese) Transcript
Japan Lifeline Earnings Call Transcript: Q2 2026
Record H1 sales and profits were driven by strong core and new segment growth, despite headwinds from PFA adoption and price revisions. International expansion and a regenerative medicine partnership marked key developments.
Japan Lifeline Quarterly report: Q2 2026
Japan Lifeline has published its Q2 2026 quarterly earnings report on October 29, 2025.
Japan Lifeline Slides: Q2 2026
Japan Lifeline has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on October 29, 2025.